For instance, EWS-FLI1, the primary oncogenic fusion of Ewing sarcoma gains the ability to bind and epigenetically convert silenced GGAA microsatellites into active enhancers (7,8). This evidence concerns the gene FLI1 and Ewing sarcoma.